"Growth Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= PLANT GROWTH REGULATORS).
| Descriptor ID |
D006131
|
| MeSH Number(s) |
D27.505.696.377.450
|
| Concept/Terms |
Growth Inhibitors- Growth Inhibitors
- Inhibitors, Growth
- Cell Growth Inhibitors
- Growth Inhibitors, Cell
- Inhibitors, Cell Growth
|
Below are MeSH descriptors whose meaning is more general than "Growth Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Growth Inhibitors".
This graph shows the total number of publications written about "Growth Inhibitors" by people in this website by year, and whether "Growth Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 5 | 2 | 7 |
| 1995 | 8 | 2 | 10 |
| 1996 | 6 | 0 | 6 |
| 1997 | 4 | 1 | 5 |
| 1998 | 5 | 5 | 10 |
| 1999 | 6 | 6 | 12 |
| 2000 | 4 | 4 | 8 |
| 2001 | 2 | 6 | 8 |
| 2002 | 6 | 1 | 7 |
| 2003 | 2 | 3 | 5 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 2 | 3 |
| 2007 | 0 | 2 | 2 |
| 2008 | 2 | 4 | 6 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 2 | 3 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Growth Inhibitors" by people in Profiles.
-
Pathogenesis of Tobacco-Associated Lung Adenocarcinoma Is Closely Coupled with Changes in the Gut and Lung Microbiomes. Int J Mol Sci. 2022 Sep 18; 23(18).
-
Cutting edge: CTLA-4 on effector T cells inhibits in trans. J Immunol. 2012 Aug 01; 189(3):1123-7.
-
Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect. Biochem Pharmacol. 2012 Mar 15; 83(6):715-22.
-
A possible clinical adaptation of CRM197 in combination with conventional chemotherapeutic agents for ovarian cancer. Anticancer Res. 2011 Jul; 31(7):2461-5.
-
Mast cell-derived IL-10 suppresses germinal center formation by affecting T follicular helper cell function. J Immunol. 2011 Jan 01; 186(1):25-31.
-
Mesenchymal stromal cells alone or expressing interferon-beta suppress pancreatic tumors in vivo, an effect countered by anti-inflammatory treatment. Cytotherapy. 2010 Sep; 12(5):615-25.
-
A profile of NSAID-targeted arachidonic acid metabolisms in human embryonic stem cells (hESCs): implication of the negative effects of NSAIDs on heart tissue regeneration. Int J Cardiol. 2011 Aug 04; 150(3):253-9.
-
Activation of nerve growth factor-induced B alpha by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth. Mol Pharmacol. 2010 Mar; 77(3):396-404.
-
Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci. 2008 Dec 03; 28(49):13161-72.
-
Synchronization of the cell cycle using lovastatin. Cell Cycle. 2008 Aug; 7(15):2434-40.